Achieving the World Health Organization's vision for clinical pharmacology

about

Progress in pharmacogenetics: consortiums and new strategies Modelling Medications for Public Health Research.From genomic medicine to precision medicine: highlights of 2015.Life-threatening drug interactions: what the physician needs to know.

P2860

Q28071652-602BFE12-999E-42F2-B1C6-6B5B83F65848 Q37607233-32BBD809-176E-46A5-8502-5EE4624E9793 Q42537218-D7E46E97-58CD-4951-8E0D-10C4549F69CD Q48145727-DEFFBD23-157A-4F01-BE04-8ABE62D3418F

P2860

Achieving the World Health Organization's vision for clinical pharmacology

Item

http://www.wikidata.org/entity/Q36802085

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Achieving the World Health Organization's vision for clinical pharmacology

@ast

Achieving the World Health Organization's vision for clinical pharmacology

@en

type

Item

label

Achieving the World Health Organization's vision for clinical pharmacology

@ast

Achieving the World Health Organization's vision for clinical pharmacology

@en

prefLabel

Achieving the World Health Organization's vision for clinical pharmacology

@ast

Achieving the World Health Organization's vision for clinical pharmacology

@en

P1476

Achieving the World Health Organization's vision for clinical pharmacology

@en

P2093

Felix Bochner

http://www.w3.org/2001/XMLSchema#string

Jean Gray

http://www.w3.org/2001/XMLSchema#string

Klaus Mörike

http://www.w3.org/2001/XMLSchema#string

Matthias Schwab

http://www.w3.org/2001/XMLSchema#string

Richard Day

http://www.w3.org/2001/XMLSchema#string

P2860

Data collection as a barrier to personalized medicine.

A manifesto for clinical pharmacology from principles to practice

HLA-B*5701 screening for hypersensitivity to abacavir.

Choosing Wisely in the UK: the Academy of Medical Royal Colleges' initiative to reduce the harms of too much medicine.

Genetic polymorphism and toxicology--with emphasis on cytochrome p450.

Omics and drug response.

Personalized pharmacogenomics: predicting efficacy and adverse drug reactions.

Adding the 'medicines' back into personalized medicine to improve cancer treatment outcomes.

P304

223-227

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BCP.12803

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-10-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

282871937

http://www.w3.org/2001/XMLSchema#string

P698

26466826

http://www.w3.org/2001/XMLSchema#string

P921

Alþjóðaheilbrigðismálastofnunin

P932

4833156

http://www.w3.org/2001/XMLSchema#string

Achieving the World Health Organization's vision for clinical pharmacology

about

P2860

P2860

Achieving the World Health Organization's vision for clinical pharmacology

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P921

P932